SCHEMBL8837568

SCHEMBL8837568

CCOC(=O)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1Cl

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 3/20 0.51
CCR6 P51684 2/20 0.51
NPC1 O15118 2/20 0.51
POLB P06746 2/20 0.51
MITF O75030 2/20 0.51
HPGD P15428 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
GALR2 O43603 1/20 0.51
HSP90AA1 P07900 1/20 0.51
XBP1 P17861 1/20 0.51
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
MCL1 Q07820 1/20 0.44
AKR1B1 P15121 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9988172 0.87 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL396778 0.85 NPC1 (0.54) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL7591886 0.84 NPC1 (0.50) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL10877588 0.84 GPR35 (0.55) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL10803120 0.84 MAPT (0.42) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL6626231 0.84 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNACCR6POLB
SCHEMBL1465652 0.83 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL11282260 0.83 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL1886725 0.81 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2LMNACCR6NPC1
SCHEMBL9761593 0.80 NPC1 (0.57) ALDH1A1SMN1; SMN2LMNACCR6NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5672617-A Medicaments containing 1-thiocarbamoyl-5-hydroxy-pyrazoles and their use as agents for combating septic shock BAYER AKTIENGESELLSCHAFT (DE) 1997-09-30 US disclosed
US-5510365-A SUPPRESSION OF TUMOR NECROSIS FACTOR (TNFALPHA) ACTIVITY BAYER AKTIENGESELLSCHAFT (DE) 1996-04-23 US disclosed